Related Experiment Video

Updated: Aug 11, 2026

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

The bacterial nucleoside N(6)-methyldeoxyadenosine induces the differentiation of mammalian tumor cells

D Ratel1, S Boisseau, S M Davidson

  • 1INSERM U318, CHU Michallon, 38033 Grenoble cedex 9, France.

Biochemical and Biophysical Research Communications
|July 17, 2001
PubMed

Insights

N(6)-methyldeoxyadenosine (MDA), a compound rare in mammalian DNA, triggers cell differentiation and expresses specific markers in various tumor cell lines. This suggests MDA

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • Mammalian DNA typically lacks N(6)-methyldeoxyadenosine (MDA), unlike bacterial DNA.
  • The biological role of MDA in eukaryotic systems is largely unexplored.
  • Understanding DNA methylation patterns is crucial for cellular function and disease.

Purpose of the Study:

  • To investigate the biological effects of N(6)-methyldeoxyadenosine (MDA) on eukaryotic tumor cell lines.
  • To determine if MDA can induce differentiation and specific cellular markers.
  • To explore the potential of MDA as a therapeutic agent.

Main Methods:

  • Treatment of various tumor cell lines (glioma, pheochromocytoma, teratocarcinoma, neuroepithelial tumor) with N(6)-methyldeoxyadenosine (MDA).
  • Analysis of cell differentiation markers, including 2',3'-cyclic nucleotide 3'phosphorylase (CNP).
  • Observation of cell cycle modifications associated with MDA treatment.

Main Results:

  • N(6)-methyldeoxyadenosine (MDA) induced significant cell differentiation in multiple tumor cell lines, including C6.9 glioma cells.
  • Expression of the oligodendroglial marker 2',3'-cyclic nucleotide 3'phosphorylase (CNP) was observed following MDA treatment.
  • Observed differentiation effects were linked to modifications in the cell cycle.
  • The study identified potential antitumoral and differentiation properties of MDA.

Conclusions:

  • N(6)-methyldeoxyadenosine (MDA) demonstrates potential as a novel antitumoral and differentiation agent for eukaryotic cells.
  • The findings raise questions about the evolutionary loss of adenine methylation in mammalian DNA.
  • MDA's ability to induce biological processes suggests potential applications in gene therapy, particularly concerning plasmid DNA injections.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Dot Blot Assay for Detecting Global N6-Methyladenosine RNA Modification Levels08:40

Dot Blot Assay for Detecting Global N6-Methyladenosine RNA Modification Levels

Published on: February 6, 2026

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...